logo BDSP

Base documentaire


Votre avis nous intéresse

Le réseau BDSP met en oeuvre un projet d'innovation et d'amélioration de ses services, dans le souci constant de proposer des contenus de qualité adaptés aux besoins des utilisateurs.

Identifier de nouvelles sources de financements est la condition nécessaire pour assurer la poursuite et la pérennité de cet outil unique qu'est la BDSP, tout en le faisant évoluer.

Pour définir un nouveau modèle économique, nous avons besoin de votre avis : merci de répondre à notre enquête (temps estimé : 5 minutes).

Participer maintenant
Participer plus tard J'ai déjà participé

  1. A cost benefit analysis of routine varicella vaccination in Spain.

    Article - En anglais

    The objective of the study was to assess varicella epidemiology and the cost of disease in Spain, in order to perform a cost-benefit analysis of universal vaccination at 15 months of age.

    Epidemiological data were obtained from a survey of 150 children with varicella, from hospitalizations and from the Spanish literature.

    A Markov decision tree was designed with two alternatives. vaccination or nonvaccination.

    Direct costs derived from the disease were lower than the cost of vaccination (ratio 0.54 : 1). however when indirect costs, such as working time loss were taken into account, vaccination was the best alternative, with a saving of PT2627 per vaccinated subject (PT1.6 recovered per peseta invested in the program).

    Sensitivity analysis shows that decreasing vaccine coverage and efficacy to 0.7, increasing the annual discount rate to 20% and with a vaccine price less than PT6000, vaccination is always the best alternative.

    In conclusion, from the economic point of view, a universal varicella vaccination program in children at 15 months of age would be justified in Spain.

    Mots-clés Pascal : Virus varicelle, Alphaherpesvirinae, Herpesviridae, Virus, Nourrisson, Homme, Varicelle, Virose, Infection, Epidémiologie, Prévalence, Programme sanitaire, Vaccination, Analyse avantage coût, Immunoprotection, Espagne, Europe, Europe Sud

    Mots-clés Pascal anglais : Varicella zoster virus, Alphaherpesvirinae, Herpesviridae, Virus, Infant, Human, Varicella, Viral disease, Infection, Epidemiology, Prevalence, Sanitary program, Vaccination, Cost benefit analysis, Immunoprotection, Spain, Europe, Southern Europe

    Logo du centre Notice produite par :
    Inist-CNRS - Institut de l'Information Scientifique et Technique

    Cote : 99-0226423

    Code Inist : 002B05A02. Création : 16/11/1999.